We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLS
101
DELISTED
Chart Industries
GTLS
$613K 0.01%
+3,720
New +$500K
SRCL
102
DELISTED
Stericycle Inc
SRCL
$603K 0.01%
+11,437
New +$575K
RCM
103
DELISTED
R1 RCM Inc. Common Stock
RCM
$601K 0.01%
46,686
+16,846
+56% +$196K
MAN icon
104
ManpowerGroup
MAN
$2.58B
$600K 0.01%
+7,731
New +$575K
V icon
105
Visa
V
$701B
$596K 0.01%
+2,137
New +$590K
VRSK icon
106
Verisk Analytics
VRSK
$28.2B
$593K 0.01%
+2,517
New +$605K
PMT
107
PennyMac Mortgage Investment
PMT
$854M
$593K 0.01%
+40,405
New +$578K
AAPL icon
108
Apple
AAPL
$4.98T
$591K 0.01%
+3,449
New +$627K
FLS icon
109
Flowserve
FLS
$9.37B
$587K 0.01%
+12,857
New +$541K
SCI icon
110
Service Corp International
SCI
$11.7B
$586K 0.01%
+7,895
New +$557K
SWKS icon
111
Skyworks Solutions
SWKS
$9.65B
$586K 0.01%
+5,407
New +$567K
SON icon
112
Sonoco
SON
$5.92B
$584K 0.01%
+10,105
New +$577K
HCSG icon
113
Healthcare Services Group
HCSG
$1.57B
$575K 0.01%
+46,036
New +$510K
ENV
114
DELISTED
ENVESTNET, INC.
ENV
$574K 0.01%
+9,905
New +$517K
IMNM icon
115
Immunome
IMNM
$2.64B
$568K 0.01%
+23,031
New +$467K
OBDC icon
116
Blue Owl Capital
OBDC
$5.45B
$565K 0.01%
36,735
+24,595
+203% +$370K
GCO icon
117
Genesco
GCO
$430M
$557K 0.01%
+19,786
New +$571K
APTV icon
118
Aptiv
APTV
$12.5B
$556K 0.01%
+6,978
New +$563K
GBDC icon
119
Golub Capital BDC
GBDC
$3.37B
$554K 0.01%
33,300
+19,345
+139% +$302K
KMB icon
120
Kimberly-Clark
KMB
$37.6B
$541K 0.01%
4,185
+704
+20% +$86.4K
ADMA icon
121
ADMA Biologics
ADMA
$2.03B
$536K 0.01%
81,204
+38,547
+90% +$211K
BBY icon
122
Best Buy
BBY
$18.9B
$530K 0.01%
+6,462
New +$492K
AMPY icon
123
Amplify Energy
AMPY
$152M
$529K 0.01%
80,005
+65,924
+468% +$401K
ZBH icon
124
Zimmer Biomet
ZBH
$18.6B
$527K 0.01%
3,992
+2,074
+108% +$259K
BJ icon
125
BJs Wholesale Club
BJ
$12.4B
$526K 0.01%
+6,956
New +$485K
3 4
5
6 7

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.